María Mar
Abad Hernández
Catedrática de Universidad
![Foto de María Mar](/img/nophoto.png)
![Foto de Instituto de Biología Molecular y Celular del Cáncer de Salamanca / Centro de Investigación del Cáncer](/img/noimage_org.png)
Instituto de Biología Molecular y Celular del Cáncer de Salamanca / Centro de Investigación del Cáncer
Salamanca, EspañaPublications in collaboration with researchers from Instituto de Biología Molecular y Celular del Cáncer de Salamanca / Centro de Investigación del Cáncer (7)
2023
-
Etiopathogenic role of ERK5 signaling in sarcoma: prognostic and therapeutic implications
Experimental and Molecular Medicine, Vol. 55, Núm. 6, pp. 1247-1257
2019
-
MEK5 promotes lung adenocarcinoma
The European respiratory journal
2017
-
Prognostic impact of a novel gene expression profile classifier for the discrimination between metastatic and non-metastatic primary colorectal cancer tumors
Oncotarget, Vol. 8, Núm. 64, pp. 107685-107700
2016
-
Genomic characterization of liver metastases from colorectal cancer patients
Oncotarget, Vol. 7, Núm. 45, pp. 72908-72922
2014
-
Active kinase profiling, genetic and pharmacological data define mTOR as an important common target in triple-negative breast cancer
Oncogene, Vol. 33, Núm. 2, pp. 148-156
2011
-
Prevalence of human papillomavirus genotypes in cytologic abnormalities from unvaccinated women living in north-western Spain
APMIS, Vol. 119, Núm. 3, pp. 204-215
2007
-
Neuregulin expression modulates clinical response to trastuzumab in patients with metastatic breast cancer
Journal of Clinical Oncology, Vol. 25, Núm. 19, pp. 2656-2663